110 related articles for article (PubMed ID: 32598254)
21. Evaluation of Changes in the Expression Profile of mRNA and Proteinencoding Adiponectin in Ishikawa Cell Line under the Influence of Cisplatin - Preliminary Report.
Kiełabsiński R; Kieszkowski P; Grabarek BO; Boroń D
Curr Pharm Biotechnol; 2020; 21(12):1242-1248. PubMed ID: 32370713
[TBL] [Abstract][Full Text] [Related]
22. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
23. Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer.
Manmuan S; Sakunrangsit N; Ketchart W
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1042-1052. PubMed ID: 28656701
[TBL] [Abstract][Full Text] [Related]
24. Interplay between miRNAs and Genes Associated with Cell Proliferation in Endometrial Cancer.
Hermyt E; Zmarzły N; Grabarek B; Kruszniewska-Rajs C; Gola J; Jęda-Golonka A; Szczepanek K; Mazurek U; Witek A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795319
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin Changes Expression of SEMA3B in Endometrial Cancer.
Peszek W; Kras P; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2020; 21(13):1368-1376. PubMed ID: 32410560
[TBL] [Abstract][Full Text] [Related]
26. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
Park YA; Lee JW; Choi JJ; Jeon HK; Cho Y; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):125-33. PubMed ID: 22015043
[TBL] [Abstract][Full Text] [Related]
27. microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.
Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2012 Oct; 27(10):3036-45. PubMed ID: 22904162
[TBL] [Abstract][Full Text] [Related]
28. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
[TBL] [Abstract][Full Text] [Related]
29. Integrated miRNA and mRNA expression profiling in fetal hippocampus with Down syndrome.
Shi WL; Liu ZZ; Wang HD; Wu D; Zhang H; Xiao H; Chu Y; Hou QF; Liao SX
J Biomed Sci; 2016 Jun; 23(1):48. PubMed ID: 27266699
[TBL] [Abstract][Full Text] [Related]
30. Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.
Zhen YF; Li ST; Zhu YR; Wang XD; Zhou XZ; Zhu LQ
Oncotarget; 2016 Nov; 7(48):79417-79427. PubMed ID: 27765904
[TBL] [Abstract][Full Text] [Related]
31. Molecular Landscape of the Epithelial-Mesenchymal Transition in Endometrioid Endometrial Cancer.
Opławski M; Nowakowski R; Średnicka A; Ochnik D; Grabarek BO; Boroń D
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917330
[TBL] [Abstract][Full Text] [Related]
32. Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin.
Indermaur MD; Xiong Y; Kamath SG; Boren T; Hakam A; Wenham RM; Apte SM; Lancaster JM
Am J Obstet Gynecol; 2010 Aug; 203(2):158.e1-40. PubMed ID: 20444440
[TBL] [Abstract][Full Text] [Related]
33. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
34. Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity.
Hermawan A; Wagner E; Roidl A
Oncol Rep; 2016 Mar; 35(3):1732-40. PubMed ID: 26708059
[TBL] [Abstract][Full Text] [Related]
35. Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor.
Hasegawa K; Ishikawa K; Kawai S; Torii Y; Kawamura K; Kato R; Tsukada K; Udagawa Y
Oncol Rep; 2013 Dec; 30(6):2937-44. PubMed ID: 24100466
[TBL] [Abstract][Full Text] [Related]
36. [Regulation of Bub1 mRNA expression in endometrial carcinoma Ishikawa cells by estrogen and paclitaxel].
Chen YH; Li XP; Wang Y; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):686-90. PubMed ID: 21092550
[TBL] [Abstract][Full Text] [Related]
37. Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer
Kieszkowski P; Dąbruś D; Grabarek BO; Boroń D
Curr Pharm Biotechnol; 2020; 21(11):1119-1128. PubMed ID: 32297576
[TBL] [Abstract][Full Text] [Related]
38. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
Zhou J; Li P; Xue X; He S; Kuang Y; Zhao H; Chen S; Zhi Q; Guo X
Toxicol Lett; 2013 Oct; 222(2):139-45. PubMed ID: 23916687
[TBL] [Abstract][Full Text] [Related]
39. Early effects of the antineoplastic agent salinomycin on mitochondrial function.
Managò A; Leanza L; Carraretto L; Sassi N; Grancara S; Quintana-Cabrera R; Trimarco V; Toninello A; Scorrano L; Trentin L; Semenzato G; Gulbins E; Zoratti M; Szabò I
Cell Death Dis; 2015 Oct; 6(10):e1930. PubMed ID: 26492365
[TBL] [Abstract][Full Text] [Related]
40. Anticancer Activity of Polyether Ionophore-Salinomycin.
Antoszczak M; Huczyński A
Anticancer Agents Med Chem; 2015; 15(5):575-91. PubMed ID: 25553435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
